Pediatrix Therapeutics

Focus: Pediatrix Therapeutics is a China-based biotechnology company focused on small molecule therapies across gastroenterology, metabolic diseases, rare diseases, and respiratory indications. The company operates from Shanghai with a specialized pipeline targeting pediatric and neonatal conditions.

Gastroenterology Metabolic Diseases Rare Diseases Respiratory

Profile data last refreshed 2d ago · AI intelligence enriched 1w ago

Open Jobs

About Pediatrix Therapeutics

AI assessmentNot Hiring

No open roles listed right now. Follow Pediatrix Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthStrong

Pipeline

Late-stage

4 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

Voxelotor

Sickle Cell Anemia

Peak

Most clinically advanced program in Phase 4; represents the flagship asset with clear regulatory pathway.

Pipeline & Clinical Trials

Help build intelligence for Pediatrix Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused pipeline in high-unmet-need pediatric/neonatal areas including sickle cell anemia (Voxelotor in Phase 4) and prematurity complications
Positioned in Shanghai with access to China's growing biotech ecosystem and emerging market opportunities
Therapeutic focus on rare diseases and metabolic disorders offers intellectual depth for specialized research roles

Watch Out For

Currently zero active job openings signals either early-stage hiring freeze or minimal expansion plans
Extremely limited public visibility—no available data on funding, revenue, employee count, or recent news creates transparency risk
Pipeline appears heavily observational/clinical trial-heavy with many non-drug interventions; unclear commercial viability of most programs

Generated by Claude from Pediatrix Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Neonatal Outcome by Reason for Delivery

Preterm Delivery

Clinical Trials (1)

NCT01818518Neonatal Outcome by Reason for Delivery

N/A

CERVIDIL

Labor Induction

N/A

Clinical Trials (1)

NCT01402050Foley Catheter Versus Cervidil for Induction of Labor at Term

N/A

Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission

Hypoglycemia

N/A

Clinical Trials (1)

NCT04085978Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission

N/A

Omegaven

Total Parenteral Nutrition-induced Cholestasis

N/A

Clinical Trials (1)

NCT02534077Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants

N/A

No intervention

Hearing Loss

N/A

Clinical Trials (1)

NCT00511381Genetic Testing in Detection of Late-Onset Hearing Loss

N/A

Randomizing to Suture or Staple closure of Cesarean section

C.Delivery; Penetration, Pregnant Uterus, by Instrument

N/A

Clinical Trials (1)

NCT02549131Cesarean Wound Closure in Women With BMI 40 or Greater

N/A

Optimal Management of Vasa Previa Study - A Retrospective Study

Vasa Previa

N/A

Clinical Trials (1)

NCT01977040Optimal Management of Vasa Previa Study - A Retrospective Study

N/A

Surveillance Study of Bacterial Contamination of the Parent's Cell Phone in the NICU

Bacterial Contamination Rate of the Cell Phones

N/A

Clinical Trials (1)

NCT01560936Surveillance Study of Bacterial Contamination of the Parent's Cell Phone in the NICU

N/A

Retrospective Chart Review

Chorioamnionitis

N/A

Clinical Trials (1)

NCT03576560Selective Use of Antibiotics in Neonates Born to Mothers With Suspected Chorioamnionitis

N/A

Determine the Incidence of Long QT Amongst a Large Cohort of Subjects Diagnosed With Unilateral or B

Sensorineural Hearing Loss

N/A

Clinical Trials (1)

NCT02082431Determine the Incidence of Long QT Amongst a Large Cohort of Subjects Diagnosed With Unilateral or Bilateral Sensorineural Hearing Loss.

N/A

VF-Test

Preterm Birth

N/A

Human Milk

Human Milk/Breastfeeding

N/A

Clinical Trials (1)

NCT02692521Human Milk Feeding Rates Post-NICU Discharge

N/A

EOS Calculator

Maternal; Chorioamnionitis, Affecting Fetus

N/A

Clinical Trials (1)

NCT04513691A Chart Review of Newborns With the Presence of Confirmed or Suspected Maternal Chorioamnionitis and Utilization of the Early Onset Sepsis Calculator

N/A

Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome

Long QT Syndrome

N/A

Clinical Trials (1)

NCT01705925Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome

N/A

Blood spot specimens will be drawn

Premature Birth

N/A

Clinical Trials (1)

NCT00675753Three Interacting Single Nucleotide Polymorphisms (SNPs) and the Risk of Preterm Birth in Black Families

N/A

Any patient eligible for an Ultrasound greater than or equal to 18 weeks gestation without a fetal or uterine anomaly.

Maternal-Fetal Exchange

N/A

Clinical Trials (1)

NCT01698957Maternal Uterine Artery Doppler Study

N/A

Similac Probiotic Tri-Blend

Total Parenteral Nutrition

N/A

Clinical Trials (1)

NCT04977817Probiotics/TPN in the NICU

N/A

Telemedicine in Pregnant Women With Type 1 Diabetes Mellitus

Type 1 Diabetes

N/A

Clinical Trials (1)

NCT04278664Telemedicine in Pregnant Women With Type 1 Diabetes Mellitus

N/A

Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids

Pregnancy Preterm

N/A

Clinical Trials (1)

NCT03738293Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids

N/A

Factors Associated With Mortality in Neonates

Neonatal Mortality

N/A

Clinical Trials (1)

NCT01215461Factors Associated With Mortality in Neonates

N/A

2 hour glucose tolerance test using 75g glucose drink

Diabetes

N/A

Clinical Trials (1)

NCT03946631GDM Post Partum Screening

N/A

The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease

Congenital Heart Disease

N/A

Clinical Trials (1)

NCT01749059The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease

N/A

PDA Post NICU Discharge

Patent Ductus Arteriosus

N/A

Clinical Trials (1)

NCT02750228PDA Post NICU Discharge

N/A

Fetal Fibronectin

Preterm Delivery

N/A

Clinical Trials (1)

NCT00156000fFN & E3 in the Prediction of PTB in Women With Twin Pregnancies Receiving 17OHP or Placebo

N/A

Gene mutation sample

Hyperbilirubinemia

N/A

Clinical Trials (1)

NCT00383318Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia

N/A

Amino Acid and Acylcarnitine Profiles in Premature Neonates

Prematurity

N/A

Clinical Trials (1)

NCT00865150Amino Acid and Acylcarnitine Profiles in Premature Neonates

N/A

No interventions or procedures

BPD - Bronchopulmonary Dysplasia

N/A

Clinical Trials (1)

NCT04971694Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes

N/A

TcB Measurement

Hyperbilirubinemia

N/A

Clinical Trials (1)

NCT03195998Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants

N/A

Nutritional Content of Breast Milk From Mothers of Premies

Prematurity

N/A

Clinical Trials (1)

NCT01050192Nutritional Content of Breast Milk From Mothers of Premies

N/A

The Effect of Standardizing the Definition of a Clinically Significant Cardiopulmonary Event on Leng

Apnea of Prematurity

N/A

Clinical Trials (1)

NCT03414671The Effect of Standardizing the Definition of a Clinically Significant Cardiopulmonary Event on Length of Stay

N/A

Nasal Continuous Positive Airway Pressure

Knee Replacement Surgery

N/A

Clinical Trials (1)

NCT01622647The Effect of Nasal Continuous Positive Airway Pressure (N-CPAP) on Arterial pCO2 During Spinal Anesthesia

N/A

Cervical Pessary Placement

Placenta Previa

N/A

Clinical Trials (1)

NCT01996345Vaginal Pessary Versus Expectant Management for Placenta Previa

N/A

Registry for Severe ROP and Treatment on Visual Outcomes

Retinopathy of Prematurity

N/A

Clinical Trials (1)

NCT01559571Registry for Severe ROP and Treatment on Visual Outcomes

N/A

Tandem MS test for inborn errors of metabolism

Hydrops Fetalis

N/A

Clinical Trials (1)

NCT00143039Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR

N/A

IV/Oral Hydration and Bedrest

Oligohydramnios

N/A

Clinical Trials (1)

NCT01682928Hydrotherapy for the Reversal of Oligohydramnios

N/A

non-invasive prenatal testing

Aneuploidy

N/A

Clinical Trials (1)

NCT02284399National Prevalence and Impact of Noninvasive Prenatal Testing

N/A

The Efficacy of Implementing a Treatment Algorithm in Managing Patent Ductus Arteriosus (PDA) in the

PDA

N/A

Clinical Trials (1)

NCT04379843The Efficacy of Implementing a Treatment Algorithm in Managing Patent Ductus Arteriosus (PDA) in the Extremely Low Birth Weight Neonatal Population.

N/A

Buprenorphine

Neonatal Abstinence Syndrome

Phase 2

Clinical Trials (1)

NCT01708707Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)

Phase 2

Betamethasone - ACTIVE

Premature Birth

Phase 2/3

Clinical Trials (1)

NCT02469519Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes